Numerous clinical trials evaluate FK506 (Tacrolimus) across Phase 1 through Phase 4, targeting conditions such as kidney, liver, and heart transplantation, organ graft rejection, acute graft-versus-host disease, BK nephropathy, and post-transplant complications. Encompassing completed, actively recruiting, and pending statuses, these studies are sponsored by major academic medical centers and pharmaceutical organizations, including Novartis, Chiesi Pharmaceuticals, Rigshospitalet, and Columbia University. Specific research includes Phase 4 evaluations of modified formulations in liver transplant recipients and Phase 2 studies examining graft-versus-host disease prophylaxis.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07524530 | NOT_YET_RECRUITING | Core Binding Factor Alpha Subunits; Hematologic Neoplasms; Leukemia; Lymphoma |
National Cancer Institute (NCI) |
2026-09-09 | PHASE2 |
| NCT05646992 | RECRUITING | Uterine Factor Infertility |
Johns Hopkins University |
2023-03-01 | PHASE2; PHASE3 |
| NCT04877288 | RECRUITING | Renal Allograft Recipients |
Bristol-Myers Squibb |
2021-07-21 | PHASE3 |
| NCT06291103 | NOT_YET_RECRUITING | Kidney Transplant Rejection |
University Hospital, Rouen |
2026-07-01 | PHASE2; PHASE3 |
| NCT05027945 | RECRUITING | Immunodeficiency; Hematopoietic Stem Cell Transplantation |
National Cancer Institute (NCI) |
2023-02-23 | PHASE2 |
| NCT04302870 | RECRUITING | Motor Neuron Disease, Amyotrophic Lateral Sclerosis |
University of Edinburgh |
2020-02-27 | PHASE2; PHASE3 |
| NCT06128070 | RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
City of Hope Medical Center |
2024-07-16 | PHASE2 |
| NCT07228624 | RECRUITING | Myelodysplastic/Myeloproliferative Neoplasm; Primary Myelofibrosis; Secondary Myelofibrosis |
Fred Hutchinson Cancer Center |
2026-02-04 | PHASE2 |
| NCT07493538 | RECRUITING | AML; MDS; Acute Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2026-04-10 | PHASE2 |
| NCT06126380 | ENROLLING_BY_INVITATION | Kidney Transplant Rejection |
Eledon Pharmaceuticals |
2023-10-25 | PHASE2 |
| NCT07412470 | RECRUITING | Kidney Transplant Rejection |
Sanofi |
2026-03-13 | PHASE2; PHASE3 |
| NCT07582172 | RECRUITING | Acute Myeloid Leukemia With Complex Karyotype; Myelodysplastic Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Recurrent Secondary Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Refractory Myelodysplastic Chronic Myelomonocytic Leukemia; Refractory Myelodysplastic Syndrome; Refractory Secondary Acute Myeloid Leukemia |
City of Hope Medical Center |
2027-04-05 | PHASE2 |
| NCT07359859 | RECRUITING | Hematologic Malignancies |
Memorial Sloan Kettering Cancer Center |
2026-01-20 | PHASE2 |
| NCT03779854 | ACTIVE_NOT_RECRUITING | Acute Biphenotypic Leukemia; Acute Leukemia; Acute Leukemia of Ambiguous Lineage; Acute Lymphoblastic Leukemia; Acute Undifferentiated Leukemia; Allogeneic Hematopoietic Stem Cell Transplantation Recipient; Blastic Plasmacytoid Dendritic Cell Neoplasm; Blasts Under 25 Percent of Bone Marrow Nucleated Cells; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome With Excess Blasts-1; Myelodysplastic Syndrome/Acute Myeloid Leukemia; Burkitt Leukemia; Chronic Monocytic Leukemia; Lymphoblastic Lymphoma; Mast Cell Leukemia; Myeloproliferative Neoplasm |
Fred Hutchinson Cancer Center |
2019-08-29 | PHASE2 |
| NCT07204275 | RECRUITING | Primary Membranous Nephropathy |
Vertex Pharmaceuticals Incorporated |
2025-09-30 | PHASE2; PHASE3 |
| NCT06815003 | RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Graft Versus Host Disease; Myelodysplastic Syndrome; Myeloproliferative Neoplasm |
City of Hope Medical Center |
2025-04-18 | PHASE2 |
| NCT07290777 | RECRUITING | Transplantation, Kidney |
Veloxis Pharmaceuticals |
2026-08-18 | PHASE2 |
| NCT07781722 | NOT_YET_RECRUITING | Post-ERCP Pancreatitis |
Amsterdam UMC, location VUmc |
2026-09-07 | PHASE4 |
| NCT06280950 | RECRUITING | Liver Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2024-09-12 | PHASE2 |
| NCT06055608 | RECRUITING | Kidney Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2024-05-22 | PHASE2 |
| NCT06235892 | RECRUITING | Organ Grafts |
Nantes University Hospital |
2024-12-10 | PHASE3 |
| NCT07612657 | NOT_YET_RECRUITING | Pulmonary Arterial Hypertension; Pulmonary Arterial Hypertension (PAH); Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH); Pulmonary Arterial Hypertension PAH; Pulmonary Arterial Hypertension WHO Group I |
VIVUS LLC |
2026-05-29 | PHASE3 |
| NCT06287944 | RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
City of Hope Medical Center |
2025-07-01 | PHASE1 |
| NCT05088356 | ACTIVE_NOT_RECRUITING | Allogeneic Hematopoietic Cell Transplantation (HCT); Advanced Hematologic Malignancies; Acute Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders |
Stanford University |
2021-09-07 | PHASE1 |
| NCT07508787 | RECRUITING | Renal Transplant Failure and Rejection |
Nefro Avillion Clinical Development, LLC |
2026-06-29 | PHASE2 |
| NCT07302776 | RECRUITING | GVHD; Hematopoietic Cell Transplantation (HCT); Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes; Myelofibrosis (MF); Chronic Myeloid Leukemia (CML); Chronic Myelomonocytic Leukemia (CMML) |
Stanford University |
2026-07-21 | PHASE1 |
| NCT03670966 | RECRUITING | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Acute Myeloid Leukemia in Remission; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome With Excess Blasts; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Refractory Mixed Phenotype Acute Leukemia; Hematopoietic and Lymphoid Cell Neoplasm |
Fred Hutchinson Cancer Center |
2019-07-10 | PHASE1; PHASE2 |
| NCT07570433 | NOT_YET_RECRUITING | CMV Infection |
Oriol Manuel |
2026-04 | PHASE4 |
| NCT04232085 | RECRUITING | Primary Immune Deficiency Disorder; Immune Deficiency Disease; Bone Marrow Failure; Short Telomere Length; Fanconi Anemia; Non Fanconi DNA-DSB Repair Disorder; Hoyeraal-Hreidarsson Syndrome; Dyskeratosis Congenita; Telomere Biology Disorder; Short Telomere Syndrome |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2020-02-12 | PHASE2 |
| NCT04542733 | ACTIVE_NOT_RECRUITING | Kidney Transplant Infection; BK Virus Infection |
King Chulalongkorn Memorial Hospital |
2023-06-15 | |
| NCT03178149 | RECRUITING | Age-Related Macular Degeneration |
Astellas Institute for Regenerative Medicine |
2018-07-13 | PHASE1 |
| NCT01861106 | RECRUITING | GATA2; Immunodeficiency; MDS |
National Cancer Institute (NCI) |
2013-07-24 | PHASE2 |
| NCT06591884 | RECRUITING | Oral Erosive Lichen Planus |
Hospital de Clinicas de Porto Alegre |
2024-09-03 | PHASE1; PHASE2 |
| NCT05707377 | ACTIVE_NOT_RECRUITING | Primary Membranous Nephropathy |
BeOne Medicines |
2023-04-17 | PHASE2; PHASE3 |
| NCT06241118 | ACTIVE_NOT_RECRUITING | Dermatitis Atopic |
Sanofi |
2024-02-29 | PHASE3 |
| NCT04022239 | RECRUITING | Hematopoietic and Lymphoid System Neoplasm |
M.D. Anderson Cancer Center |
2020-03-13 | PHASE1; PHASE2 |
| NCT06828796 | RECRUITING | Hematologic Disease and Disorders; Hematopoietic Cell Transplant |
Northside Hospital, Inc. |
2025-07-03 | PHASE2 |
| NCT04469842 | RECRUITING | Lung Transplant; Complications |
Vanderbilt University Medical Center |
2023-12-01 | EARLY_PHASE1 |
| NCT06120140 | ACTIVE_NOT_RECRUITING | Carcinoma, Non-Small-Cell Lung |
Janssen Research & Development, LLC |
2024-02-16 | PHASE2 |
| NCT04370301 | RECRUITING | Primary Myelofibrosis; Secondary Myelofibrosis |
Fred Hutchinson Cancer Center |
2021-02-09 | PHASE2 |
| NCT04859946 | ACTIVE_NOT_RECRUITING | Hematologic and Lymphocytic Disorder |
M.D. Anderson Cancer Center |
2022-01-11 | PHASE2 |
| NCT07138742 | NOT_YET_RECRUITING | Vernal Keratoconjunctivitis |
Sohag University |
2025-09 | |
| NCT05736419 | RECRUITING | Sickle Cell Disease; Thalassemia, Beta; Thalassemia |
Memorial Sloan Kettering Cancer Center |
2023-02-09 | PHASE2 |
| NCT05621759 | ACTIVE_NOT_RECRUITING | Graft Vs Host Disease |
NYU Langone Health |
2022-09-07 | PHASE2 |
| NCT01804634 | RECRUITING | Refractory and/or Relapsed Metastatic Solid Tumors |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2013-03-27 | PHASE2 |
| NCT07162896 | NOT_YET_RECRUITING | Atopic Dermatitis; Atopic Dermatitis (AD) |
Shalamar Institute of Health Sciences |
2026-06 | PHASE3 |
| NCT06084780 | NOT_YET_RECRUITING | Secondary Malignant Neoplasm of Retroperitoneum; Secondary Malignant Neoplasm of Peritoneum; Pseudomyxoma Peritonei |
Case Comprehensive Cancer Center |
2026-08 | PHASE2 |
| NCT03769298 | RECRUITING | Kidney Pancreas Transplantation |
University of Wisconsin, Madison |
2019-02-27 | PHASE2; PHASE3 |
| NCT06315309 | RECRUITING | GVHD,Acute; Acute Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders |
University of Alabama at Birmingham |
2025-04-15 | PHASE2 |
| NCT06701825 | RECRUITING | Kidney Disease, Chronic; Transplant Recipient (Kidney); Immunosuppression |
Instituto de Investigación Hospital Universitario La Paz |
2025-06-02 | PHASE4 |
| NCT03467386 | SUSPENDED | Acute Myeloid Leukemia |
City of Hope Medical Center |
2018-03-19 | PHASE1 |
| NCT04904588 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Mixed Phenotype Acute Leukemia; Acute Leukemia; Myelodysplastic Syndromes; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Lymphoma |
Center for International Blood and Marrow Transplant Research |
2021-09-30 | PHASE2 |
| NCT06203470 | NOT_YET_RECRUITING | Psoriasis Vulgaris |
Assiut University |
2024-06 | PHASE4 |
| NCT04384692 | ACTIVE_NOT_RECRUITING | Primary Myelofibrosis; Secondary Myelofibrosis |
Fred Hutchinson Cancer Center |
2020-12-18 | PHASE2 |
| NCT06900777 | RECRUITING | Vitiligo; Child; Progressive Disease |
Xijing Hospital |
2025-04-01 | |
| NCT03121014 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia; Myelodysplastic Syndromes |
University of Illinois at Chicago |
2017-04-24 | PHASE2 |
| NCT06405100 | NOT_YET_RECRUITING | Minimal Change Disease |
Air Force Military Medical University, China |
2024-05 | PHASE3 |
| NCT07367932 | NOT_YET_RECRUITING | Dermatitis, Atopic; Eczema |
Cairo University |
2026-02 | PHASE4 |
| NCT06306274 | ENROLLING_BY_INVITATION | Lymphedema |
Odense University Hospital |
2024-09-09 | PHASE2; PHASE3 |
| NCT03292861 | ENROLLING_BY_INVITATION | Heart Transplantation |
Cedars-Sinai Medical Center |
2018-09-13 | PHASE2 |
| NCT07532330 | ACTIVE_NOT_RECRUITING | Vitiligo |
Minia University |
2025-08-01 | |
| NCT04965597 | COMPLETED | Bone Marrow Failure Syndrome; Congenital Amegakaryocytic Thrombocytopenia; Diamond-Blackfan Anemia; Hereditary Sideroblastic Anemia; Paroxysmal Nocturnal Hemoglobinuria; Shwachman-Diamond Syndrome; Hematologic Neoplasm With Germline GATA2 Mutation; Hematologic Neoplasm With Germline SAMD9 Mutation; Hematologic Neoplasm With Germline SAMD9L Mutation |
Fred Hutchinson Cancer Center |
2022-04-19 | PHASE2 |
| NCT05089604 | RECRUITING | Liver Transplantation; Immunosuppression; Neurotoxicity; Tremor; Tacrolimus |
University of British Columbia |
2023-01-09 | PHASE4 |
| NCT06348602 | UNKNOWN | Ocular Graft-versus-host Disease |
Hospital Universitario Dr. Jose E. Gonzalez |
2023-08-01 | PHASE1; PHASE2 |
| NCT04207177 | UNKNOWN | Kidney Transplant; Complications; Immune Suppression |
Oslo University Hospital |
2019-10-30 | PHASE4 |
| NCT04177004 | ACTIVE_NOT_RECRUITING | Allogeneic Hematopoietic Stem Cell Transplant Recipient; Hematopoietic and Lymphoid Cell Neoplasm |
City of Hope Medical Center |
2021-04-30 | PHASE1 |
| NCT06867042 | NOT_YET_RECRUITING | Ulcerative Colitis (UC); Ulcerative Colitis, Active Moderate |
Jina Pharmaceuticals Inc. |
2025-04 | PHASE2 |
| NCT05148715 | ACTIVE_NOT_RECRUITING | Organ Transplant Failure or Rejection; Brain Death; Ischemic Reperfusion Injury |
Université de Sherbrooke |
2022-07-11 | PHASE2 |
| NCT05156710 | ACTIVE_NOT_RECRUITING | Transplant Rejection |
Sanofi |
2022-06-09 | PHASE2 |
| NCT05907746 | ACTIVE_NOT_RECRUITING | GATA2; Immunodeficiency |
National Cancer Institute (NCI) |
2023-11-29 | PHASE2 |
| NCT06638879 | COMPLETED | Chronic Graft Versus Host Disease Oral |
Children's Hospital Medical Center, Cincinnati |
2024-09-17 | PHASE1 |
| NCT05490511 | COMPLETED | CBD; Transplant Complication; Kidney Disease, Chronic |
Indiana University |
2022-10-31 | PHASE1 |
| NCT05916781 | UNKNOWN | Systemic Lupus Erythematosus; Lupus Nephritis |
Chinese SLE Treatment And Research Group |
2023-07-01 | PHASE4 |
| NCT04665310 | ACTIVE_NOT_RECRUITING | Kidney Disease, End-Stage; Donor Specific Antibodies; Acute Rejection of Renal Transplant |
The Methodist Hospital Research Institute |
2018-09-01 | PHASE4 |
| NCT06183892 | RECRUITING | Liver Transplant |
RenJi Hospital |
2024-03-04 | |
| NCT06880042 | ENROLLING_BY_INVITATION | Vitiligo - Macular Depigmentation; Tacrolimus |
Dr ayesha wahid |
2025-05-01 | EARLY_PHASE1 |
| NCT05115630 | COMPLETED | Myeloid Malignancies; Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia |
M.D. Anderson Cancer Center |
2022-04-08 | PHASE2 |
| NCT04380311 | COMPLETED | Heart Transplant Failure and Rejection |
University of Utah |
2020-05-01 | |
| NCT03663933 | ACTIVE_NOT_RECRUITING | Lymphoproliferative Disorders; Autoimmune Lymphoproliferative; Primary T-cell Immunodeficiency Disorders; Immune System Diseases; Common Variable Immunodeficiency |
National Cancer Institute (NCI) |
2018-09-04 | PHASE2 |
| NCT07030660 | COMPLETED | Kidney Transplantation |
KU Leuven |
2021-05-11 | |
| NCT03480360 | COMPLETED | Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myeloid Leukemia; Myelodysplasia; Myeloproliferative Disorder; Myelofibrosis; Lymphoma; Lymphoma, Non-Hodgkin; Plasma Cell Disorder |
Dartmouth-Hitchcock Medical Center |
2018-03-28 | PHASE3 |
| NCT05256537 | ACTIVE_NOT_RECRUITING | Hematologic Neoplasms |
Ronald Paquette |
2022-04-26 | PHASE2 |
| NCT05666336 | UNKNOWN | Systemic Lupus Erythematosus |
Fen Li |
2022-12-31 | PHASE4 |
| NCT03689075 | TERMINATED | Kidney Transplant Failure; Allosensitization; Immunosuppression |
Imperial College Healthcare NHS Trust |
2018-11-01 | PHASE4 |
| NCT01203722 | COMPLETED | Hematologic Malignancies |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-09 | PHASE1; PHASE2 |
| NCT05005221 | COMPLETED | Kidney Transplant |
University of Michigan |
2022-11-08 | |
| NCT04942730 | COMPLETED | Leukemia, Acute Lymphoblastic; Myeloid Leukemia, Acute; Biphenotypic Acute Leukemia; Lymphoblastic Lymphoma; Myelodysplastic Syndromes; Myeloproliferative Neoplasm |
St. Petersburg State Pavlov Medical University |
2021-01-21 | PHASE2 |
| NCT05702931 | Not yet recruiting | Hyperglycemia|Renal Transplant Complication Primary Non-Function|Diabetes |
Rigshospitalet Denmark|Aarhus University Hospital|Odense University Hospital |
2024-04-01 | Phase 4 |
| NCT05152628 | COMPLETED | Liver Transplantation; Kidney Transplantation |
Astellas Pharma China, Inc. |
2022-01-11 | PHASE4 |
| NCT06268769 | Recruiting | Immunosuppression |
Edward Geissler|Chiesi Pharmaceuticals GmbH|University of Regensburg |
2024-03-09 | Phase 4 |
| NCT06326775 | Active not recruiting | Heart Transplant Patients |
Nanjing First Hospital Nanjing Medical University|Wuhan Union Hospital China|Changhai Hospital|Shanghai Zhongshan Hospital |
2024-03-12 | -- |
| NCT04773392 | TERMINATED | Kidney Transplantation; Kidney Transplant Rejection |
University of Southern California |
2021-11-23 | PHASE4 |
| NCT02566304 | COMPLETED | Acute Myeloid Leukemia; Acute Myeloid Leukemia in Remission; Aplastic Anemia; Chronic Myelomonocytic Leukemia; Hodgkin Lymphoma; Indolent Non-Hodgkin Lymphoma; Malignant Neoplasm; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Plasma Cell Myeloma; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ring Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2015-11-13 | PHASE2 |
| NCT06235892 | Not yet recruiting | Organ Grafts |
Nantes University Hospital |
2024-02-10 | Phase 3 |
| NCT04646356 | COMPLETED | Hereditary Hemorrhagic Telangiectasia; Epistaxis Nosebleed |
Unity Health Toronto |
2020-10-20 | PHASE2 |
| NCT03410654 | COMPLETED | Kidney Transplant; Complications |
Yale University |
2018-10-24 | EARLY_PHASE1 |
| NCT07049172 | COMPLETED | Nephrotic Syndrome in Children |
Wuhan Children's Hospital |
2021-01-01 | |
| NCT05618730 | UNKNOWN | Dry Eye; Keratoconjunctivitis Sicca; Ocular Inflammation |
Eximore Ltd. |
2022-09-29 | PHASE1 |
| NCT02382575 | UNKNOWN | Nephrotic Syndrome |
Nilratan Sircar Medical College |
2015-03-15 | PHASE4 |
| NCT04311632 | COMPLETED | Kidney Transplantation |
ITB-Med LLC |
2021-05-26 | PHASE2 |
| NCT05532111 | UNKNOWN | Efficacy and Safety |
RenJi Hospital |
2022-09-01 | |
| NCT05293509 | WITHDRAWN | Stem Cell Transplantation |
M.D. Anderson Cancer Center |
2022-03-02 | PHASE2 |
| NCT01810588 | COMPLETED | Hematologic Malignancies |
Weill Medical College of Cornell University |
2012-10-16 | PHASE2 |
| NCT05396898 | COMPLETED | Posttransplant Diabetes Mellitus |
University Hospital Tuebingen |
2020-12-16 | PHASE4 |
| NCT02711826 | COMPLETED | Kidney Transplant; Adult Living Donor Kidney Transplant Recipients; Renal Transplant; Living Kidney Donor |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-09-20 | PHASE1; PHASE2 |
| NCT03461445 | COMPLETED | Kidney Transplant; Complications; Toxicity; Drug Toxicity; Neurotoxicity |
University of California, Davis |
2018-04-01 | PHASE4 |
| NCT03500848 | UNKNOWN | Liver Transplantation |
Southern Medical University, China |
2018-05-01 | PHASE2; PHASE3 |
| NCT04048161 | COMPLETED | Nephrotic Syndrome in Children |
The Children's Hospital of Zhejiang University School of Medicine |
2019-11-12 | PHASE4 |
| NCT04489134 | COMPLETED | Pharmacokinetics |
Rennes University Hospital |
2022-02-15 | PHASE2 |
| NCT02766465 | COMPLETED | Sickle Cell Disease |
Medical College of Wisconsin |
2017-03-16 | PHASE2 |
| NCT05885269 | COMPLETED | Alopecia Areata |
Combined Military Hospital Abbottabad |
2022-11-01 | PHASE1 |
| NCT03781414 | TERMINATED | Liver Transplant Rejection |
Novartis Pharmaceuticals |
2019-10-07 | PHASE2 |
| NCT03386539 | COMPLETED | Pediatric Heart Transplantation; Immunosuppression; Chronic Kidney Diseases; Cardiac Allograft Vasculopathy; Heart Transplant Failure and Rejection; Post-transplant Lymphoproliferative Disorder; Heart Transplant Infection |
Boston Children's Hospital |
2018-01-29 | PHASE3 |
| NCT04154735 | WITHDRAWN | Crohn's Disease |
Northwestern University |
2019-11 | PHASE2 |
| NCT04669210 | COMPLETED | Graft-versus-host-disease; Stem Cell Transplant Complications; Acute Myeloid Leukemia; Acute Lymphoid Leukemia |
St. Petersburg State Pavlov Medical University |
2020-11-03 | PHASE2 |
| NCT03995901 | TERMINATED | Transplanted Organ Rejection |
Talaris Therapeutics Inc. |
2019-10-25 | PHASE3 |
| NCT02960646 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Aplastic Anemia; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Lymphoblastic Lymphoma; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Plasma Cell Myeloma; Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Therapy-Related Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2017-01-18 | PHASE1 |
| NCT05221411 | UNKNOWN | Autoimmune Hepatitis |
Leiden University Medical Center |
2022-01-19 | PHASE4 |
| NCT03531281 | WITHDRAWN | Hematopoietic and Lymphoid Cell Neoplasm; Hematopoietic Cell Transplantation Recipient |
City of Hope Medical Center |
2018-12-30 | PHASE1 |
| NCT04503616 | COMPLETED | Graft-versus-host Disease |
NYU Langone Health |
2020-09-16 | PHASE1; PHASE2 |
| NCT04420195 | COMPLETED | Lung Transplant |
NYU Langone Health |
2020-10-23 | PHASE2 |
| NCT02582775 | COMPLETED | Epidermolysis Bullosa |
Masonic Cancer Center, University of Minnesota |
2016-03 | PHASE2 |
| NCT02837978 | COMPLETED | Arthritis, Rheumatoid |
Qiang Shu |
2015-01 | PHASE4 |
| NCT04903054 | WITHDRAWN | Kidney Transplantation; Renal Transplant Recipients |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-01-10 | PHASE2 |
| NCT02122081 | COMPLETED | Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia |
Sumithira Vasu |
2015-07-27 | PHASE1 |
| NCT04002115 | TERMINATED | Acute Myeloid Leukemia |
Milton S. Hershey Medical Center |
2020-06-03 | PHASE2 |
| NCT02342145 | COMPLETED | Beta-Thalassemia Major; Graft-versus-host Disease (GVHD) |
Zhongming Zhang |
2015-04 | PHASE4 |
| NCT01572662 | COMPLETED | Leukemia; Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Chronic Myeloid Leukemia; Chronic Lymphocytic Leukemia; Myeloproliferative Diseases; Non-Hodgkins Lymphoma; Hodgkins Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2012-04-11 | PHASE2 |
| NCT04403321 | COMPLETED | Aplastic Anemia; Drug Effect |
Peking Union Medical College Hospital |
2020-07-01 | PHASE2 |
| NCT03794492 | COMPLETED | Kidney Transplant |
Chong Kun Dang Pharmaceutical |
2018-03-31 | PHASE4 |
| NCT03864926 | COMPLETED | Delayed Graft Function |
University of Wisconsin, Madison |
2019-03-18 | PHASE4 |
| NCT05353010 | UNKNOWN | Healthy |
HK inno.N Corporation |
2022-05-01 | PHASE1 |
| NCT03789006 | UNKNOWN | Kidney Transplant Rejection |
University of Khartoum |
2018-03-21 | PHASE4 |
| NCT01904136 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Acute Myeloid Leukemia With Gene Mutations; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Therapy-Related Acute Myeloid Leukemia |
M.D. Anderson Cancer Center |
2014-04-22 | PHASE1; PHASE2 |
| NCT03088709 | TERMINATED | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome; Non-hodgkin Lymphoma; Chronic Lymphocytic Leukemia |
Loyola University |
2017-01-18 | PHASE2 |
| NCT02248597 | COMPLETED | Graft Versus Host Disease; Hematopoietic/Lymphoid Cancer |
Wake Forest University Health Sciences |
2015-02-25 | PHASE2 |
| NCT04541290 | COMPLETED | Breast Cancer Lymphedema |
Odense University Hospital |
2020-09-22 | PHASE1; PHASE2 |
| NCT04810143 | COMPLETED | Validate Volumetric Absorptive Microsampling (VAMS) Assay |
Children's Hospital Medical Center, Cincinnati |
2019-10-07 | |
| NCT03171831 | UNKNOWN | Thalassemia Major |
First Affiliated Hospital of Guangxi Medical University |
2017-04-01 | PHASE4 |
| NCT02867800 | COMPLETED | Sickle Cell Disease; Graft Versus Host Disease |
Monica Bhatia |
2016-07 | PHASE1 |
| NCT03614221 | COMPLETED | Atopic Dermatitis |
Chang Gung Memorial Hospital |
2019-06-03 | PHASE2 |
| NCT02909335 | WITHDRAWN | Liver Transplantation |
Rennes University Hospital |
2016-11 | PHASE3 |
| NCT05139667 | COMPLETED | Oral Lichen Planus |
Ain Shams University |
2019-05-20 | PHASE4 |
| NCT02918292 | COMPLETED | Severe Aplastic Anemia |
Medical College of Wisconsin |
2017-07-03 | PHASE2 |
| NCT04590183 | UNKNOWN | Posner Schlossman Syndrome |
Peking University |
2020-10-01 | |
| NCT01665677 | COMPLETED | Graft vs Host Disease |
Mehdi Hamadani |
2014-01-20 | PHASE2 |
| NCT02833805 | COMPLETED | Severe Aplastic Anemia; Aplastic Anemia; Bone Marrow Failure; Immunosuppression |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2016-09 | PHASE2 |
| NCT00423514 | COMPLETED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes |
Memorial Sloan Kettering Cancer Center |
2006-11-20 | PHASE1; PHASE2 |
| NCT02866682 | COMPLETED | Renal Transplant Rejection |
University of California, Los Angeles |
2018-03-01 | PHASE4 |
| NCT04725682 | COMPLETED | Healthy Volunteers |
Food and Drug Administration (FDA) |
2021-01-05 | PHASE1 |
| NCT04205240 | TERMINATED | Recurrent Plasma Cell Myeloma |
Srinivas Devarakonda |
2020-12-22 | PHASE2 |
| NCT02556931 | COMPLETED | Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Chronic Myeloid Leukemia; Chronic Myeloproliferative Disorders; Multiple Myeloma; Plasma Cell Neoplasm; Plasma Cell Dyscrasia; Myelofibrosis; Polycythemia Vera; Essential Thrombocythemia; Plasma Cell Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2015-12 | PHASE2 |
| NCT04114097 | COMPLETED | Atopic Dermatitis; Atopic Eczema |
Jacob Thyssen |
2019-08-22 | PHASE4 |
| NCT02736227 | COMPLETED | Liver Transplantation |
Northwestern University |
2016-03 | |
| NCT03289650 | COMPLETED | End Stage Renal Disease; Rejection of Renal Transplant |
Lorenzo Gallon |
2017-09-05 | PHASE3 |
| NCT04069065 | UNKNOWN | Liver Transplant |
Chong Kun Dang Pharmaceutical |
2019-07-31 | PHASE4 |
| NCT03315052 | WITHDRAWN | Acute Cellular Graft Rejection; Liver Transplant Rejection |
Montefiore Medical Center |
2019-01 | PHASE4 |
| NCT03277430 | UNKNOWN | Mayer Rokitansky Kuster Hauser Syndrome; Mullerian Aplasia; Uterus; Absence, Congenital; Infertility, Female; Uterus Absence, Acquired; Absolute Uterine Factor Infertility |
Institute for Clinical and Experimental Medicine |
2015-10-09 | PHASE3 |
| NCT02921789 | COMPLETED | Kidney Transplantation; Primary Focal Segmental Glomerulosclerosis (FSGS) |
Astellas Pharma Global Development, Inc. |
2017-05-22 | PHASE2 |
| NCT04114188 | COMPLETED | Renal Transplant Rejection |
Prof. Dr. Petra Reinke |
2016-12-15 | PHASE2 |
| NCT02345850 | COMPLETED | Acute Leukemia; Myelodysplasia |
National Heart, Lung, and Blood Institute (NHLBI) |
2015-08 | PHASE3 |
| NCT01095172 | UNKNOWN | Function of Renal Transplant |
Guy's and St Thomas' NHS Foundation Trust |
2010-11 | PHASE4 |
| NCT02540395 | COMPLETED | Disorder Related to Renal Transplantation; Effects of Immunosuppressant Therapy |
Prof. Dr. Petra Reinke |
2015-03 | |
| NCT04127721 | WITHDRAWN | Allogeneic Stem Cell Transplant Recipient; Hematologic and Lymphocytic Disorder; Hematopoietic and Lymphoid Cell Neoplasm |
M.D. Anderson Cancer Center |
2020-09-22 | PHASE2 |
| NCT03465410 | COMPLETED | KIDNEY TRANSPLANTATION |
NURIA LLOBERAS BLANCH |
2017-03-21 | PHASE4 |
| NCT03918265 | UNKNOWN | Autoimmune Hemolytic Anemia; Pure Red Cell Aplasia; Evans Syndrome |
Peking Union Medical College Hospital |
2019-05-04 | PHASE4 |
| NCT01935128 | COMPLETED | Renal Transplant |
University of Toledo Health Science Campus |
2013-07-03 | PHASE4 |
| NCT04258423 | TERMINATED | Kidney Failure |
Indiana University |
2019-12-19 | PHASE3 |
| NCT03674411 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Biphenotypic/Undifferentiated Leukemia; Chronic Myelogenous Leukemia; Myelodysplasia; Relapsed Large Cell Lymphoma; Mantle Cell Lymphoma; Hodgkin Lymphoma; Burkitt Lymphoma; Relapsed T-Cell Lymphoma; Lymphoplasmacytic Lymphoma |
Masonic Cancer Center, University of Minnesota |
2019-01-02 | PHASE2 |
| NCT02663622 | COMPLETED | Graft Versus Host Disease; Hematopoietic Stem Cell Transplantation; Leukemia |
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) |
2016-09-19 | PHASE2 |
| NCT03527238 | COMPLETED | Liver Transplant; Kidney Transplant |
University of Florida |
2018-09-21 | PHASE2 |
| NCT04341038 | UNKNOWN | COVID-19; Lung Injury |
Hospital Universitari de Bellvitge |
2020-04-01 | PHASE3 |
| NCT03978494 | WITHDRAWN | Kidney Transplant |
Sandoz |
2019-09-02 | PHASE1 |
| NCT03270462 | COMPLETED | Renal Transplant Patients |
University of Colorado, Denver |
2017-12-01 | PHASE4 |
| NCT02917096 | COMPLETED | Primary Myelofibrosis; Secondary Myelofibrosis |
City of Hope Medical Center |
2016-11-13 | PHASE1 |
| NCT03437577 | COMPLETED | Kidney Transplant Failure and Rejection |
University of Minnesota |
2018-05-08 | PHASE1; PHASE2 |
| NCT04023760 | COMPLETED | Pharmacokinetics; Kidney Transplant; Lung Transplant |
University of Saskatchewan |
2019-06-26 | PHASE4 |
| NCT04147390 | UNKNOWN | Keratopathy |
Shahid Beheshti University of Medical Sciences |
2019-11 | PHASE2; PHASE3 |
| NCT03066466 | WITHDRAWN | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome |
Loyola University |
2019-12-10 | PHASE3 |
| NCT01685411 | TERMINATED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Masonic Cancer Center, University of Minnesota |
2013-01 | |
| NCT03062813 | UNKNOWN | Hepatitis B Virus Associated Nephrotic Syndrome |
Guangdong Provincial People's Hospital |
2017-02-01 | PHASE4 |
| NCT01885689 | ACTIVE_NOT_RECRUITING | Adult Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia in Remission; Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Therapy-Related Myelodysplastic Syndrome |
City of Hope Medical Center |
2014-02-10 | PHASE2 |
| NCT02752529 | UNKNOWN | Cirrhosis, Liver |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2016-03 | |
| NCT05032248 | COMPLETED | Oral Ulcer; Behcet Syndrome |
Assiut University |
2019-04-01 | |
| NCT01820572 | COMPLETED | Kidney Transplantation |
Bristol-Myers Squibb |
2013-03-27 | PHASE3 |
| NCT04041219 | COMPLETED | Immunosuppression; Stem Cell Transplant; Bone Marrow Transplant |
Mayo Clinic |
2019-06-17 | PHASE4 |
| NCT03076151 | COMPLETED | Transplantation; Kidney; Pharmacokinetic |
University Hospital, Limoges |
2018-02-12 | PHASE4 |
| NCT01955187 | COMPLETED | MEMBRANOUS NEPHROPATHY |
Hospital Universitario 12 de Octubre |
2014-01 | PHASE3 |
| NCT02188719 | TERMINATED | Liver Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-12-17 | PHASE1 |
| NCT00880815 | COMPLETED | CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma |
M.D. Anderson Cancer Center |
2009-02-17 | PHASE1 |
| NCT02627573 | TERMINATED | Leukemia, Chronic Myeloid; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative |
St. Petersburg State Pavlov Medical University |
2015-07 | PHASE2 |
| NCT00857389 | COMPLETED | Stem Cell Transplantation; Leukemia; Lymphoma |
M.D. Anderson Cancer Center |
2009-03-02 | PHASE2 |
| NCT02435901 | COMPLETED | Sickle Cell Disease; Beta Thalassemia-Major |
Northwell Health |
2008-12 | PHASE1; PHASE2 |
| NCT01265537 | COMPLETED | Acute Graft Rejection; Diabetes |
University of British Columbia |
2011-06-24 | |
| NCT01570348 | TERMINATED | Crohn Disease |
Fred Hutchinson Cancer Center |
2012-07-17 | PHASE2 |
| NCT03865888 | COMPLETED | Dry Eye; Sjogren Syndrome |
Pavly Moawd |
2018-10-30 | PHASE3 |
| NCT02954159 | TERMINATED | Ulcerative Colitis |
Medical College of Wisconsin |
2017-05-18 | PHASE3 |
| NCT02077556 | COMPLETED | Drug Interaction Potentiation |
National Taiwan University Hospital |
2014-04 | PHASE4 |
| NCT03358082 | UNKNOWN | Vitiligo; Tacrolimus |
Sohag University |
2017-10-01 | PHASE1; PHASE2 |
| NCT02145403 | COMPLETED | Hematologic Malignancies; Relapse; Graft-Versus-Host Disease |
University of Michigan Rogel Cancer Center |
2014-10 | PHASE1; PHASE2 |
| NCT03365141 | UNKNOWN | Vitiligo; Treatment; Intralesional Injection; Corticosteroid |
The Catholic University of Korea |
2017-11-14 | |
| NCT03465969 | COMPLETED | Kidney Transplantation; Liver Transplantation |
Astellas Pharma Europe Ltd. |
2018-03-20 | PHASE4 |
| NCT02953873 | COMPLETED | Immunosuppression |
Medical University of South Carolina |
2017-05-05 | PHASE4 |
| NCT02652468 | COMPLETED | Lymphoma |
University of Wisconsin, Madison |
2016-03-10 | |
| NCT02961608 | COMPLETED | Kidney Transplant; Complications |
Hospital Universitari de Bellvitge |
2016-05 | PHASE4 |
| NCT02882113 | UNKNOWN | Liver Dysfunction |
Seoul National University Hospital |
2016-07 | PHASE4 |
| NCT02120157 | COMPLETED | Myeloablative Conditioning; HLA-mismatched Bone Marrow Transplantation; Graft Survival; Transplantation, Bone Marrow |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2015-07-02 | PHASE2 |
| NCT04761731 | COMPLETED | Liver Transplantation |
Linical Korea |
2015-07 | PHASE4 |
| NCT02217410 | COMPLETED | Kidney Transplantation |
Novartis Pharmaceuticals |
2015-02-05 | PHASE1; PHASE2 |
| NCT01878786 | TERMINATED | Delayed Graft Function |
Matthew Cooper |
2013-06 | PHASE2; PHASE3 |
| NCT02208037 | COMPLETED | Acute Leukemia; Chronic Myelogenous Leukemia; Myelodysplasia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Hodgkin's Lymphoma |
National Heart, Lung, and Blood Institute (NHLBI) |
2014-08 | PHASE2 |
| NCT03347357 | COMPLETED | Nephrotic Syndrome |
Shandong University |
2012-01-01 | PHASE4 |
| NCT02653196 | TERMINATED | Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation |
Montefiore Medical Center |
2015-09 | EARLY_PHASE1 |
| NCT03423225 | COMPLETED | Liver Transplantation |
Kim, Seoung-Hoon |
2016-03-22 | PHASE4 |
| NCT03083782 | COMPLETED | Venous Thromboembolism; Pharmacokinetics; Healthy |
Thomas Jefferson University |
2017-04-18 | PHASE1 |
| NCT02199041 | TERMINATED | Hematological Malignancies |
St. Jude Children's Research Hospital |
2014-07-11 | PHASE2 |
| NCT01875237 | TERMINATED | Leukemia; Myeloma; Myeloproliferative Diseases |
M.D. Anderson Cancer Center |
2013-12-27 | PHASE1; PHASE2 |
| NCT01580865 | COMPLETED | Lupus Nephritis |
Ramathibodi Hospital |
2012-05 | |
| NCT02432833 | COMPLETED | End Stage Renal Disease |
Chiesi Farmaceutici S.p.A. |
2015-05 | PHASE4 |
| NCT01790568 | COMPLETED | Graft vs Host Disease; Hematologic Neoplasms; Non-Neoplastic Hematologic and Lymphocytic Disorder |
University of Michigan Rogel Cancer Center |
2014-12 | PHASE2 |
| NCT02083991 | COMPLETED | Diabetes Mellitus |
Vastra Gotaland Region |
2013-01 | PHASE4 |
| NCT02178683 | UNKNOWN | Graft Versus Host Disease |
Colorado Blood Cancer Institute |
2010-11 | PHASE3 |
| NCT02456025 | UNKNOWN | Vernal Keratoconjunctivitis |
The Eye Center and The Eye Foundation for Research in Ophthalmology |
2013-04 | PHASE4 |
| NCT01649609 | COMPLETED | BK Viremia; BK Nephropathy |
Columbia University |
2012-03 | |
| NCT02373202 | COMPLETED | Rheumatoid Arthritis |
Sanofi |
2015-02 | PHASE3 |
| NCT01159080 | COMPLETED | Kidney Transplantation |
Asan Medical Center |
2010-04-01 | PHASE4 |
| NCT00589316 | TERMINATED | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; CD45-Positive Neoplastic Cells Present; Chronic Myelomonocytic Leukemia; Previously Treated Myelodysplastic Syndrome; Refractory Anemia With Excess Blasts; Refractory Anemia With Ring Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts |
Fred Hutchinson Cancer Center |
2007-10-05 | PHASE1 |
| NCT00498316 | COMPLETED | Myelodysplastic Syndrome; Leukemia |
M.D. Anderson Cancer Center |
2007-07-03 | PHASE1 |
| NCT02601703 | COMPLETED | Atopic Dermatitis |
Glenmark Pharmaceuticals Ltd. India |
2015-08 | PHASE3 |
| NCT02528877 | WITHDRAWN | Acute Myeloid Leukemia in Remission; Primary Myelofibrosis; Primary Myelofibrosis, Prefibrotic Stage; Secondary Acute Myeloid Leukemia; Secondary Myelofibrosis |
City of Hope Medical Center |
2015-11 | PHASE1 |
| NCT02438982 | COMPLETED | Nephrotic Syndrome |
Nilratan Sircar Medical College |
2015-05-08 | PHASE3 |
| NCT01790594 | TERMINATED | Simultaneous Kidney and Pancreas Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-02 | PHASE2 |
| NCT01318915 | TERMINATED | Renal Transplant Recipients |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-07-25 | EARLY_PHASE1 |
| NCT02794610 | UNKNOWN | Ocular Penetration of Topical Tacrolimus |
The Eye Center and The Eye Foundation for Research in Ophthalmology |
2016-05 | |
| NCT01860183 | COMPLETED | Kidney Transplantation; Kidney Failure |
Clinical Hospital Merkur |
2013-05 | PHASE4 |
| NCT01598987 | COMPLETED | Renal Function; Liver Transplant |
Novartis Pharmaceuticals |
2012-10 | PHASE3 |
| NCT00533442 | COMPLETED | Type 1 Diabetes |
University of Miami |
2000-09 | PHASE2 |
| NCT01856257 | TERMINATED | Primary Renal Allograft Candidate; Kidney Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-07 | PHASE2 |
| NCT01451489 | TERMINATED | FSGS |
Nanjing University School of Medicine |
2011-10-13 | |
| NCT01895049 | COMPLETED | Kidney Transplantation; Cytomegalovirus |
Helio Tedesco Silva Junior |
2013-08 | PHASE4 |
| NCT01655563 | COMPLETED | Heart Transplantation; Liver Transplantation; Kidney Transplantation |
The Hospital for Sick Children |
2011-09 | PHASE2 |
| NCT01911546 | COMPLETED | Highly-sensitized Kidney Transplant Recipients |
Joseph Kahwaji, MD, MPH |
2013-06 | PHASE2 |
| NCT01889758 | COMPLETED | Kidney Transplant Recipients; Liver Transplant Recipients |
University of Cincinnati |
2013-06 | PHASE4 |
| NCT01680952 | COMPLETED | Kidney Transplant Patients |
Yonsei University |
2012-09 | PHASE4 |
| NCT02644395 | COMPLETED | Hypertension; Kidney Transplantation |
Erasmus Medical Center |
2013-01-18 | PHASE3 |
| NCT01586845 | WITHDRAWN | Renal Transplantation |
Aurinia Pharmaceuticals Inc. |
2013-03 | PHASE3 |
| NCT00448357 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
UNC Lineberger Comprehensive Cancer Center |
2005-10 | PHASE1; PHASE2 |
| NCT01294020 | COMPLETED | Intestine Transplantation; Kidney Transplantation; Lung Transplantation; Liver Transplantation; Heart Transplantation |
Astellas Pharma Europe Ltd. |
2011-05-25 | PHASE2 |
| NCT02130817 | WITHDRAWN | End Stage Renal Disease; Antibody Mediated Rejection |
University of Wisconsin, Madison |
2014-09-24 | PHASE4 |
| NCT00881556 | TERMINATED | Epidermolysis Bullosa |
Columbia University |
2009-08-20 | EARLY_PHASE1 |
| NCT01649427 | COMPLETED | Pharmacokinetics Study in de Novo Kidney Transplantation |
Novartis Pharmaceuticals |
2012-10-17 | PHASE4 |
| NCT02014103 | COMPLETED | Complication of Transplant |
University of Cincinnati |
2015-03 | PHASE4 |
| NCT02496494 | UNKNOWN | CYCLOSPORINE/TACROLIMUS |
Kyungpook National University Hospital |
2012-09 | PHASE4 |
| NCT02744378 | COMPLETED | Oral Lichen Planus |
University of Peradeniya |
2014-06 | PHASE2 |
| NCT00933231 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2009-08-17 | PHASE3 |
| NCT01511003 | COMPLETED | Rheumatoid Arthritis |
Astellas Pharma Inc |
2011-12-05 | PHASE4 |
| NCT01436305 | TERMINATED | Kidney Transplantation; Renal Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-09 | PHASE2 |
| NCT00993343 | COMPLETED | Graft-versus-host Disease; Survival |
Karolinska Institutet |
2007-09 | PHASE3 |
| NCT01544842 | TERMINATED | Oral Lichen Planus |
University of Oulu |
2004-08 | |
| NCT02123108 | COMPLETED | Liver Transplantation |
University of California, Los Angeles |
2011-01 | PHASE4 |
| NCT01055964 | COMPLETED | Pharmacokinetics; Tacrolimus |
Seoul National University Hospital |
2008-09 | PHASE3 |
| NCT01680861 | COMPLETED | Transplant; Failure, Kidney |
Gaetano Ciancio |
2012-11 | PHASE3 |
| NCT01334333 | COMPLETED | Renal Disease; Renal Transplant |
University of British Columbia |
2011-11-11 | PHASE4 |
| NCT01713400 | COMPLETED | Graft vs. Host Disease |
H. Lee Moffitt Cancer Center and Research Institute |
2013-02-25 | PHASE2 |
| NCT01518153 | TERMINATED | Leukemia; Lymphoma; Myeloma; Myeloproliferative Diseases |
M.D. Anderson Cancer Center |
2012-02 | PHASE2 |
| NCT01244659 | WITHDRAWN | Renal Transplant |
EMS |
2014-05 | PHASE3 |
| NCT01608412 | UNKNOWN | Kidney Transplant Recipients |
Hospital de Clinicas de Porto Alegre |
2012-02 | PHASE4 |
| NCT01780844 | COMPLETED | Kidney Transplantation |
Astellas Pharma Global Development, Inc. |
2013-03-05 | PHASE2 |
| NCT00931255 | TERMINATED | Kidney Transplant; Delayed Graft Function |
University of Maryland, Baltimore |
2009-04 | PHASE4 |
| NCT01339468 | COMPLETED | Liver Transplantation |
Astellas Pharma Inc |
2011-04-27 | PHASE4 |
| NCT00371319 | COMPLETED | Lupus Nephritis |
Tuen Mun Hospital |
2005-09 | PHASE4 |
| NCT01647945 | COMPLETED | Pulmonary Arterial Hypertension |
Edda Spiekerkoetter |
2012-07 | PHASE2 |
| NCT02016625 | COMPLETED | Healthy |
Boehringer Ingelheim |
2013-12 | PHASE1 |
| NCT00801632 | COMPLETED | Kidney Transplantation; Kidney Failure, Chronic |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-12 | PHASE2 |
| NCT01789255 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; B-cell Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Graft Versus Host Disease; Intraocular Lymphoma; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Post-transplant Lymphoproliferative Disorder; Primary Central Nervous System Hodgkin Lymphoma; Primary Central Nervous System Non-Hodgkin Lymphoma; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ringed Sideroblasts; Refractory Chronic Lymphocytic Leukemia; Refractory Cytopenia With Multilineage Dysplasia; Refractory Hairy Cell Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Central Nervous System Hodgkin Lymphoma; Secondary Central Nervous System Non-Hodgkin Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2013-06 | PHASE2 |
| NCT00089011 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage I Small Lymphocytic Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Multiple Myeloma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Small Lymphocytic Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome; Testicular Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia; Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2004-04 | PHASE2 |
| NCT01120028 | COMPLETED | Kidney Transplantation |
University of Oxford |
2010-09 | PHASE2; PHASE3 |
| NCT00263328 | COMPLETED | Kidney Transplantation |
Pfizer |
2005-12 | PHASE2 |
| NCT00720629 | TERMINATED | Graft Versus Host Disease |
H. Lee Moffitt Cancer Center and Research Institute |
2007-12 | PHASE2 |
| NCT01702181 | COMPLETED | Atopic Dermatitis |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2012-08 | PHASE1 |
| NCT01698541 | COMPLETED | End Stage Renal Disease |
University of Oslo School of Pharmacy |
2013-02 | PHASE4 |
| NCT00623012 | TERMINATED | Graft Versus Host Disease |
Yale University |
2008-02 | PHASE1; PHASE2 |
| NCT00789308 | COMPLETED | Diabetes Mellitus, Type I |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-07-11 | PHASE2 |
| NCT01564095 | TERMINATED | Terminal Liver Disease; Ischemia Reperfusion Injury; Graft Dysfunction; Graft Failure; Poor Graft Quality |
Ludwig-Maximilians - University of Munich |
2011-10 | PHASE2; PHASE3 |
| NCT01154387 | UNKNOWN | End Stage Renal Disease; Renal Transplant |
Tolera Therapeutics, Inc |
2010-07 | PHASE1; PHASE2 |
| NCT00965094 | COMPLETED | Chronic Renal Failure |
Novartis Pharmaceuticals |
2009-12 | PHASE4 |
| NCT02108301 | UNKNOWN | Chronic Hepatitis C-virus Infection; Renal Transplantation |
Prof. Dr. Alice Schmidt |
2011-12 | PHASE4 |
| NCT00731874 | TERMINATED | Immunosuppression |
Weill Medical College of Cornell University |
2008-08 | PHASE4 |
| NCT01841008 | TERMINATED | Pigmentation Disorders; Vitiligo |
Centre Hospitalier Universitaire de Nice |
2011-12 | PHASE2; PHASE3 |
| NCT00973804 | TERMINATED | Leukemia; Non-Hodgkins Lymphoma; Hodgkins Lymphoma; MDS; Multiple Myeloma |
National Cancer Institute (NCI) |
2009-08-25 | PHASE1 |
| NCT00938860 | COMPLETED | Hepatitis C; Liver Transplantation |
Novartis Pharmaceuticals |
2009-09 | PHASE4 |
| NCT01742676 | COMPLETED | Renal Transplantation; Kidney Transplantation; Stable Renal Recipients |
Astellas Pharma Korea, Inc. |
2011-04 | PHASE4 |
| NCT00693446 | UNKNOWN | Pancreas Transplantation; Kidney Transplantation |
Nantes University Hospital |
2004-04 | PHASE4 |
| NCT01476488 | COMPLETED | Kidney Transplantation; Pediatric Patients; Maintenance With Tacrolimus |
Seoul National University Hospital |
2011-07 | PHASE2; PHASE3 |
| NCT00332839 | TERMINATED | Renal Transplantation |
Novartis Pharmaceuticals |
2005-11 | PHASE4 |
| NCT01187953 | COMPLETED | Renal Failure |
Veloxis Pharmaceuticals |
2010-09 | PHASE3 |
| NCT00513474 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Massachusetts General Hospital |
2008-01 | PHASE1 |
| NCT01323920 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndrome |
Dana-Farber Cancer Institute |
2011-05 | PHASE2 |
| NCT01044745 | TERMINATED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Graft Versus Host Disease; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Waldenström Macroglobulinemia |
University of Nebraska |
2009-12-10 | PHASE2 |
| NCT00803010 | COMPLETED | Acute Graft Versus Host Disease |
H. Lee Moffitt Cancer Center and Research Institute |
2008-09 | PHASE2 |
| NCT01068067 | UNKNOWN | Renal Transplantation |
Sun Yat-sen University |
2010-03 | |
| NCT00669890 | TERMINATED | Acute Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome |
New York Medical College |
2004-05 | PHASE1 |
| NCT00934791 | TERMINATED | Polycystic Liver Disease |
Mayo Clinic |
2009-02 | |
| NCT00956059 | UNKNOWN | Focal Segmental Glomerulosclerosis |
Xi'an Jiaotong University |
2009-09 | |
| NCT02963103 | TERMINATED | Kidney Transplantation |
Astellas Pharma Korea, Inc. |
2010-05 | PHASE4 |
| NCT00076570 | COMPLETED | Kidney Transplantation |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2004-01 | PHASE2 |
| NCT00859131 | COMPLETED | End Stage Renal Disease |
Medical University of South Carolina |
2009-03 | |
| NCT01742624 | COMPLETED | de Novo Kidney Transplantation |
Astellas Pharma Korea, Inc. |
2012-04 | PHASE4 |
| NCT01399242 | UNKNOWN | Disorder Related to Renal Transplantation |
Hospital Universitário São José |
2011-08 | PHASE4 |
| NCT01135329 | TERMINATED | Lymphoma; Leukemia; Myelodysplastic Syndrome |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-08 | PHASE2 |
| NCT01312064 | TERMINATED | Renal Insufficiency |
National Taiwan University Hospital |
2011-04 | PHASE4 |
| NCT00622869 | COMPLETED | Liver Transplantation |
Novartis Pharmaceuticals |
2008-01 | PHASE3 |
| NCT01161459 | COMPLETED | Idiopathic Membranous Nephropathy |
Zhi-Hong Liu, M.D. |
2010-06 | |
| NCT00322101 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Acute Myeloid Leukemia/Transient Myeloproliferative Disorder; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Acute Myeloid Leukemia in Remission; Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2006-01 | PHASE3 |
| NCT00589563 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition; Secondary Myelofibrosis; Small Intestine Cancer |
City of Hope Medical Center |
2007-05 | PHASE2 |
| NCT00639717 | COMPLETED | Graft Versus Host Disease |
University of Michigan Rogel Cancer Center |
2009-03 | PHASE2 |
| NCT01160276 | COMPLETED | Renal Replacement Therapies |
Assistance Publique - Hôpitaux de Paris |
2010-05 | PHASE1 |
| NCT01206569 | COMPLETED | Lupus Nephritis |
Chinese University of Hong Kong |
2010-09 | PHASE4 |
| NCT00464555 | COMPLETED | Type 1 Diabetes Mellitus |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-12 | PHASE2 |
| NCT01850979 | COMPLETED | Sjogren Syndrome; Dry Eye Syndrome |
University of Sao Paulo General Hospital |
2010-02 | PHASE4 |
| NCT01122719 | TERMINATED | Stable Coronary Disease; Unstable Coronary Disease; Documented Silent Ischemia |
CID - Carbostent & Implantable Devices |
2010-10 | |
| NCT01309477 | COMPLETED | Nephrotic Syndrome |
Sun Yat-sen University |
2011-01 | PHASE3 |
| NCT01328834 | COMPLETED | Nephritis, Lupus |
Sun Yat-sen University |
2011-01 | PHASE3 |
| NCT00972101 | WITHDRAWN | Stem Cell Transplantation; Leukemia; Lymphoma; Pediatric Disorders |
M.D. Anderson Cancer Center |
2009-09 | PHASE1 |
| NCT00737659 | UNKNOWN | Renal Transplant |
Rabin Medical Center |
2008-08 | PHASE4 |
| NCT00585468 | COMPLETED | Kidney Transplantation |
University of Utah |
2007-12 | PHASE4 |
| NCT01224028 | COMPLETED | IgA Nephropathy |
Astellas Pharma Inc |
2010-11 | PHASE2 |
| NCT00246129 | COMPLETED | Kidney Transplantation; Kidney Diseases; Kidney Failure |
EMagnusson |
2005-10 | PHASE4 |
| NCT01224041 | COMPLETED | Rheumatoid Arthritis |
Astellas Pharma Inc |
2009-08 | PHASE4 |
| NCT01591070 | COMPLETED | Seborrheic Dermatitis |
Pusan National University Hospital |
2010-11 | PHASE4 |
| NCT00876616 | COMPLETED | Lupus Nephritis |
Zhi-Hong Liu, M.D. |
2009-04 | |
| NCT00105001 | COMPLETED | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndrome; Refractory Chronic Lymphocytic Leukemia; Refractory Plasma Cell Myeloma; Waldenstrom Macroglobulinemia; Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA; Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Lymphoma; Childhood Myelodysplastic Syndrome; Stage II Contiguous Adult Burkitt Lymphoma; Stage II Contiguous Adult Diffuse Large Cell Lymphoma; Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma; Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma; Stage II Adult Contiguous Immunoblastic Lymphoma; Stage II Contiguous Adult Lymphoblastic Lymphoma; Stage II Grade 1 Contiguous Follicular Lymphoma; Stage II Grade 2 Contiguous Follicular Lymphoma; Stage II Grade 3 Contiguous Follicular Lymphoma; Stage II Contiguous Mantle Cell Lymphoma; Stage II Non-Contiguous Adult Burkitt Lymphoma; Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma; Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma; Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma; Stage II Adult Non-Contiguous Immunoblastic Lymphoma; Stage II Non-Contiguous Adult Lymphoblastic Lymphoma; Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Stage II Non-Contiguous Mantle Cell Lymphoma; Stage II Small Lymphocytic Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Burkitt Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Secondary Myelodysplastic Syndrome; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Immunoblastic Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Burkitt Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Burkitt Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Burkitt Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Burkitt Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma |
Fred Hutchinson Cancer Center |
2004-11 | PHASE2 |
| NCT00049504 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hematopoietic/Lymphoid Cancer; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage II Multiple Myeloma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Hodgkin Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2002-01 | PHASE2 |
| NCT00543569 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2008-02 | PHASE2 |
| NCT00316810 | COMPLETED | Pancreas-Kidney Transplantation |
Dr. Claudia Bösmüller |
2006-04 | PHASE3 |
| NCT00448201 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
UNC Lineberger Comprehensive Cancer Center |
2011-01-07 | PHASE2 |
| NCT00360685 | COMPLETED | Mucositis; Graft-versus-host Disease |
H. Lee Moffitt Cancer Center and Research Institute |
2005-09 | |
| NCT00922129 | WITHDRAWN | Prostate Cancer |
St. Joseph's Healthcare Hamilton |
2009-09 | PHASE2; PHASE3 |
| NCT00504348 | COMPLETED | Interstitial Pneumonitis; Polymyositis; Dermatomyositis |
Tokyo Medical and Dental University |
2007-07 | PHASE2; PHASE3 |
| NCT01324934 | TERMINATED | Renal Transplant Rejection |
Neovii Biotech |
2006-10 | PHASE3 |
| NCT00311311 | TERMINATED | Atherosclerosis; Kidney Failure |
Pfizer |
2006-04 | PHASE3 |
| NCT00489203 | COMPLETED | Hematopoietic/Lymphoid Cancer; Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Atypical Chronic Myeloid Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Graft Versus Host Disease; Isolated Plasmacytoma of Bone; Juvenile Myelomonocytic Leukemia; Meningeal Chronic Myelogenous Leukemia; Myelodysplastic/Myeloproliferative Disease, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Multiple Myeloma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma |
Fred Hutchinson Cancer Center |
2007-04 | PHASE2 |
| NCT01764581 | COMPLETED | Liver Disease |
University of Bologna |
2008-07 | |
| NCT03751332 | COMPLETED | Immunosuppression; Renal Failure |
Medical University of Vienna |
2008-03 | PHASE4 |
| NCT00555048 | TERMINATED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2007-09 | PHASE1; PHASE2 |
| NCT01388517 | COMPLETED | Pityriasis Alba |
Universidad Autonoma de San Luis Potosí |
2008-01 | PHASE4 |
| NCT00787761 | COMPLETED | Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Northside Hospital, Inc. |
2007-04 | PHASE2 |
| NCT00369226 | COMPLETED | Hematologic Malignancies |
Dana-Farber Cancer Institute |
2006-08 | PHASE1; PHASE2 |
| NCT01413685 | TERMINATED | Renal Transplant Rejection |
Assistance Publique - Hôpitaux de Paris |
2009-01 | PHASE4 |
| NCT00492661 | COMPLETED | Renal Transplantion; Kidney Transplantion |
Janssen-Cilag Pty Ltd |
2007-07 | PHASE4 |
| NCT01183247 | COMPLETED | Comparative Study; Immunosuppressive Agents |
University Hospital, Basel, Switzerland |
2008-07 | PHASE4 |
| NCT00771745 | COMPLETED | Renal Transplant Rejection; Transplants and Implants |
University of Cincinnati |
2008-09 | PHASE4 |
| NCT01092806 | COMPLETED | Post Transplant Diabetes Mellitus |
University of Oslo School of Pharmacy |
2009-10 | PHASE4 |
| NCT00302536 | WITHDRAWN | Focal Glomerulosclerosis |
Nanjing University School of Medicine |
2006-03 | |
| NCT01038167 | COMPLETED | Hepatitis C |
Vertex Pharmaceuticals Incorporated |
2010-01 | PHASE1 |
| NCT00909571 | COMPLETED | Liver Transplantation |
Astellas Pharma Inc |
2009-04 | PHASE3 |
| NCT02660684 | COMPLETED | Graft Versus Host Disease |
Astellas Pharma Korea, Inc. |
2008-02 | PHASE4 |
| NCT00833079 | COMPLETED | Atopic Dermatitis |
Sun Pharmaceutical Industries, Inc. |
2008-10 | PHASE1 |
| NCT00765661 | COMPLETED | Kidney Failure; Renal Failure |
Veloxis Pharmaceuticals |
2008-09 | PHASE2 |
| NCT00733733 | UNKNOWN | Renal Transplant Patients; Recipients of a Kidney From a Non-Heart-Beating Donor |
Radboud University Medical Center |
2008-01 | PHASE3 |
| NCT01709136 | TERMINATED | Hypertension |
University of Pittsburgh |
2005-12 | PHASE2; PHASE3 |
| NCT00538265 | COMPLETED | Liver Transplantation |
University Hospital, Toulouse |
2005-05 | PHASE4 |
| NCT00223041 | TERMINATED | Renal Transplantation |
University Hospital Schleswig-Holstein |
2003-04 | PHASE2; PHASE3 |
| NCT00506922 | COMPLETED | Leukemia; Lymphoma |
M.D. Anderson Cancer Center |
2000-09 | PHASE1; PHASE2 |
| NCT00240994 | COMPLETED | Kidney Failure, Chronic; Kidney Transplantation; Immunosuppression |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-01 | PHASE2 |
| NCT02118896 | COMPLETED | Heart Transplantation; Liver Transplantation; Kidney Transplantation |
Astellas Pharma Europe Ltd. |
2003-02-24 | PHASE3 |
| NCT00790439 | WITHDRAWN | Diabetes Mellitus, Type I |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-07 | PHASE2 |
| NCT01550445 | UNKNOWN | Disorder Related to Renal Transplantation |
Ajou University School of Medicine |
2008-05 | PHASE4 |
| NCT00654355 | COMPLETED | Atopic Dermatitis |
Wake Forest University |
2008-04 | PHASE4 |
| NCT00720408 | COMPLETED | Liver Transplantation; Transplantation Immunology; Host vs Graft Reaction |
Astellas Pharma Inc |
2007-12 | PHASE3 |
| NCT00436722 | TERMINATED | Liver Diseases |
Hospital Clinic of Barcelona |
2006-06 | PHASE2 |
| NCT00301951 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of California, San Francisco |
2004-09 | PHASE1 |
| NCT01828879 | COMPLETED | Dermatitis, Atopic |
Janssen-Cilag Ltd.,Thailand |
2007-11 | PHASE4 |
| NCT00299221 | COMPLETED | Immunosuppression |
Newark Beth Israel Medical Center |
2004-04 | PHASE4 |
| NCT00472082 | TERMINATED | Kidney Transplantation; Chronic Kidney Failure |
Emory University |
2007-05 | PHASE1; PHASE2 |
| NCT00481481 | COMPLETED | Transplantation |
Astellas Pharma Inc |
2007-04 | PHASE3 |
| NCT00481819 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2007-07 | PHASE3 |
| NCT00113269 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2005-05 | PHASE4 |
| NCT00596947 | TERMINATED | Transplants and Implants |
University of Pennsylvania |
2005-10 | PHASE4 |
| NCT00619398 | COMPLETED | Liver Transplantation |
Astellas Pharma Inc |
2008-01 | PHASE3 |
| NCT00282282 | COMPLETED | Graft Versus Host Disease; GVHD |
Dana-Farber Cancer Institute |
2006-01 | PHASE2 |
| NCT00298506 | COMPLETED | Lupus Nephritis |
Nanjing University School of Medicine |
2005-09 | |
| NCT00779792 | UNKNOWN | Dermatitis, Contact; Dermatitis, Occupational |
Odense University Hospital |
2008-09 | PHASE4 |
| NCT00282256 | COMPLETED | Liver Transplantation |
Astellas Pharma Inc |
2004-01 | PHASE2 |
| NCT00319917 | COMPLETED | Rheumatoid Arthritis |
Astellas Pharma Inc |
2006-04 | PHASE4 |
| NCT00170053 | COMPLETED | Kidney Diseases |
Mayo Clinic |
2005-06 | PHASE1 |
| NCT00818194 | COMPLETED | Healthy |
Astellas Pharma Inc |
2008-04 | PHASE1 |
| NCT00615667 | COMPLETED | Kidney Diseases; Nephrotic Syndrome; Tacrolimus |
Sun Yat-sen University |
2006-06 | PHASE3 |
| NCT00452361 | TERMINATED | Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-04 | PHASE4 |
| NCT01269684 | WITHDRAWN | Kidney Transplantation |
Novartis Pharmaceuticals |
2008-08 | PHASE4 |
| NCT00118742 | COMPLETED | Liver Transplantation |
Hoffmann-La Roche |
2005-08 | PHASE4 |
| NCT00905515 | COMPLETED | Kidney Transplantation |
East Carolina University |
2003-08 | PHASE4 |
| NCT00719745 | COMPLETED | Liver Transplantation |
Astellas Pharma Inc |
2006-02 | PHASE3 |
| NCT00295607 | COMPLETED | Hepatitis C; Liver Transplantation |
Astellas Pharma Inc |
2005-06 | PHASE2 |
| NCT00403416 | COMPLETED | Kidney Transplantation |
Novartis Pharmaceuticals |
2006-10 | PHASE1; PHASE2 |
| NCT00643071 | COMPLETED | Ulcerative Colitis |
Astellas Pharma Inc |
2006-09 | PHASE3 |
| NCT00038948 | COMPLETED | Renal Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2002-01 | PHASE3 |
| NCT00104975 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Yale University |
2005-02 | PHASE1 |
| NCT00525681 | COMPLETED | Renal Transplantation |
University of Oslo School of Pharmacy |
2007-09 | PHASE4 |
| NCT00117702 | TERMINATED | Graft vs Host Disease |
Technische Universität Dresden |
2005-10 | PHASE2; PHASE3 |
| NCT00492869 | COMPLETED | Kidney Transplantation |
Novartis Pharmaceuticals |
2007-01 | PHASE1; PHASE2 |
| NCT00347048 | COMPLETED | Ulcerative Colitis |
Astellas Pharma Inc |
2006-09 | PHASE3 |
| NCT00608517 | TERMINATED | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Vanderbilt-Ingram Cancer Center |
2005-09 | |
| NCT00167557 | WITHDRAWN | Hepatitis C |
The University of Texas Health Science Center, Houston |
2005-01 | PHASE4 |
| NCT00321113 | COMPLETED | KIDNEY TRANSPLANTATION |
Astellas Pharma Inc |
2004-09 | PHASE3 |
| NCT00611351 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis |
University of Nebraska |
2005-06-07 | PHASE2 |
| NCT00121186 | TERMINATED | Lymphoma |
SWOG Cancer Research Network |
2005-07 | PHASE2 |
| NCT00374231 | COMPLETED | Liver Transplantation |
University of Cincinnati |
2002-10 | PHASE4 |
| NCT00374803 | COMPLETED | End Stage Renal Disease (ESRD) |
University of Cincinnati |
2006-04 | PHASE4 |
| NCT00865137 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2007-09 | PHASE3 |
| NCT00384202 | COMPLETED | Transplantation |
Astellas Pharma Inc |
2006-10 | PHASE3 |
| NCT00275535 | COMPLETED | Kidney Diseases |
Mayo Clinic |
2001-04 | PHASE4 |
| NCT00321074 | COMPLETED | LIVER TRANSPLANTATION |
Astellas Pharma Inc |
2005-05 | PHASE3 |
| NCT01080534 | COMPLETED | Healthy Volunteers |
Panacea Biotec Ltd |
2007-09 | |
| NCT01080482 | COMPLETED | Healthy Volunteers |
Panacea Biotec Ltd |
2007-09 | |
| NCT01080456 | COMPLETED | Healthy Volunteers |
Panacea Biotec Ltd |
2007-09 | |
| NCT00087581 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2004-06 | PHASE4 |
| NCT00293917 | COMPLETED | Psoriasis |
Astellas Pharma Inc |
2006-01 | PHASE3 |
| NCT00384137 | COMPLETED | Transplantation |
Astellas Pharma Inc |
2006-10 | PHASE3 |
| NCT00295594 | COMPLETED | Liver Transplantation |
Astellas Pharma Inc |
2005-03 | PHASE3 |
| NCT00014469 | COMPLETED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Memorial Sloan Kettering Cancer Center |
2000-12 | PHASE2 |
| NCT00133172 | TERMINATED | Kidney Transplantation |
Astellas Pharma Inc |
2005-07 | PHASE4 |
| NCT00189839 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2004-08 | PHASE3 |
| NCT00053196 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myeloproliferative Neoplasms |
Alliance for Clinical Trials in Oncology |
2002-12 | PHASE2 |
| NCT00141037 | COMPLETED | Kidney Diseases; Kidney Transplantation; Kidney Transplant; Renal Transplantation; Renal Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2004-03 | PHASE1; PHASE2 |
| NCT00148746 | COMPLETED | Moderate to Severe Atopic Dermatitis |
Technische Universität Dresden |
2004-05 | |
| NCT00912678 | COMPLETED | Kidney Transplantation |
University of Luebeck |
2002-03 | PHASE4 |
| NCT00296361 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2004-10 | PHASE3 |
| NCT00109993 | COMPLETED | Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell Tumor |
Case Comprehensive Cancer Center |
2005-01 | PHASE2 |
| NCT00027573 | COMPLETED | Kidney Cancer |
Alliance for Clinical Trials in Oncology |
2001-10 | PHASE2 |
| NCT00171743 | COMPLETED | Liver Transplant |
Novartis |
2004-04 | PHASE4 |
| NCT00089947 | COMPLETED | Renal Transplantation; Graft Rejection |
Genzyme, a Sanofi Company |
2003-06 | PHASE2 |
| NCT00239876 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2005-05 | PHASE3 |
| NCT00170833 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2003-11 | PHASE3 |
| NCT00656266 | TERMINATED | End-stage Liver Disease; Renal Insufficiency; Renal Failure |
Baylor College of Medicine |
2004-11 | PHASE4 |
| NCT00480610 | COMPLETED | Dermatitis, Atopic |
Astellas Pharma Inc |
2004-04 | PHASE3 |
| NCT00189735 | COMPLETED | Kidney Transplantation; Renal Transplantation; Transplantation, Renal; Transplantation, Kidney; Grafting, Kidney |
Astellas Pharma Inc |
2003-09 | PHASE2 |
| NCT00523952 | COMPLETED | Dermatitis, Atopic |
Astellas Pharma Inc |
2004-01 | PHASE3 |
| NCT00189787 | COMPLETED | Asthma, Bronchial; Bronchial Asthma |
Astellas Pharma Inc |
PHASE2 | |
| NCT01068054 | COMPLETED | Keratoconjunctivitis, Vernal |
Siriraj Hospital |
2003-06 | PHASE2; PHASE3 |
| NCT00644761 | COMPLETED | Hepatitis B |
Gilead Sciences |
2004-02 | PHASE2 |
| NCT00056966 | COMPLETED | Hematologic Malignancy |
Baylor College of Medicine |
2002-11 | PHASE1; PHASE2 |
| NCT00089037 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2003-06 | PHASE1; PHASE2 |
| NCT00691145 | COMPLETED | Dermatitis, Atopic |
Astellas Pharma Inc |
2002-10 | PHASE3 |
| NCT00691262 | COMPLETED | Dermatitis, Atopic |
Astellas Pharma Inc |
2003-10 | PHASE3 |
| NCT00285194 | COMPLETED | Type 1 Diabetes; Hypoglycemia |
University of Minnesota |
2000-04 | PHASE1; PHASE2 |
| NCT00002809 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Temple University |
1996-08 | PHASE2 |
| NCT00666302 | COMPLETED | Dermatitis, Atopic |
Astellas Pharma Inc |
2002-10 | PHASE4 |
| NCT00034528 | TERMINATED | Hemoglobinopathies; Anemia, Sickle Cell; Hemoglobin SC Disease; Thalassemia; Thalassemia Major |
National Institute of Allergy and Infectious Diseases (NIAID) |
2001-09 | PHASE2 |
| NCT00048399 | TERMINATED | Graft Failure |
Baylor College of Medicine |
2000-12 | PHASE1; PHASE2 |
| NCT00056979 | TERMINATED | Inherited Metabolic Storage Diseases |
Baylor College of Medicine |
2002-06 | PHASE1; PHASE2 |
| NCT00002792 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
1996-06 | PHASE2 |
| NCT00006747 | COMPLETED | Graft Versus Host Disease; Lymphoma |
Alliance for Clinical Trials in Oncology |
2000-11 | PHASE2 |
| NCT00041288 | TERMINATED | Leukemia; Lymphoma |
University of Texas Southwestern Medical Center |
2001-10 | PHASE2 |
| NCT00003572 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1998-08 | PHASE2 |
| NCT00006350 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of Maryland, Baltimore |
2000-01 | PHASE2 |
| NCT00134394 | COMPLETED | Psoriasis |
University of Medicine and Dentistry of New Jersey |
2005-02 | PHASE2 |
| NCT00286871 | COMPLETED | Chronic Hepatitis C; Organ Transplantation; Immunosuppression |
Duke University |
2006-02 | PHASE1 |
| NCT00028171 | COMPLETED | Kidney Transplantation |
National Center for Research Resources (NCRR) |
||
| NCT00195429 | COMPLETED | Kidney Failure; Graft vs Host Disease |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-08 | PHASE4 |
| NCT00178425 | COMPLETED | Transplantation, Liver |
University of Rochester |
2005-01 | PHASE4 |
| NCT00007787 | COMPLETED | Kidney Transplantation; Chronic Allograft Nephropathy |
National Institute of Allergy and Infectious Diseases (NIAID) |
2000-04 | |
| NCT00510913 | COMPLETED | Graft Rejection; Kidney Transplantation |
Astellas Pharma Inc |
1999-02 | PHASE4 |
| NCT00560378 | COMPLETED | Dermatitis, Atopic; Eczema, Atopic |
Astellas Pharma Inc |
1998-06 | PHASE3 |
| NCT00141804 | UNKNOWN | Kidney Transplantation |
University Hospital Muenster |
2002-01 | PHASE3 |
| NCT00567762 | COMPLETED | Keratoconjunctivitis; Conjunctivitis |
Astellas Pharma Inc |
2004-02 | PHASE3 |
| NCT01268995 | TERMINATED | New Onset Diabetes Mellitus After Renal Transplantation |
Medical University of Vienna |
2009-09 | PHASE2 |
| NCT00807690 | COMPLETED | Vitiligo |
Oslo University Hospital |
2005-11 | PHASE3 |
| NCT00518271 | COMPLETED | Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2000-04 | PHASE2 |
| NCT00004255 | COMPLETED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes |
Chimeric Therapies |
2000-03 | PHASE2; PHASE3 |
| NCT00166842 | UNKNOWN | Transplantation; Kidney Transplantation; Immunosuppression |
National Taiwan University Hospital |
2002-09 | PHASE4 |
| NCT00175253 | COMPLETED | Type 1 Diabetes |
University of Alberta |
2005-11 | PHASE2 |
| NCT00140543 | COMPLETED | Diabetes Mellitus, Type 1; Diabetic Nephropathy |
EUROSPK Study Group |
2002-02 | PHASE3 |
| NCT00261820 | COMPLETED | Graft Rejection; Kidney Failure; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
PHASE4 | |
| NCT00325325 | UNKNOWN | Kidney Diseases |
Hospital Universitario Ramon y Cajal |
2006-01 | PHASE2 |
| NCT00195988 | COMPLETED | Liver Transplantation |
Children's Memorial Health Institute, Poland |
2002-09 | PHASE4 |
| NCT00223015 | COMPLETED | Renal Transplantation |
University Hospital Schleswig-Holstein |
2004-05 | PHASE4 |
| NCT00236106 | COMPLETED | Atopic Dermatitis |
Children´s Clinic, Randers |
2005-02 | PHASE4 |
| NCT00304720 | UNKNOWN | Multiple Myeloma; Lymphoma; Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome |
Colorado Blood Cancer Institute |
2004-03 | PHASE2 |
| NCT00293891 | COMPLETED | Psoriasis |
Astellas Pharma Inc |
PHASE3 | |
| NCT00116103 | COMPLETED | Asthma |
Astellas Pharma Inc |
2005-06 | PHASE2 |
| NCT00177099 | COMPLETED | Alopecia |
Hordinsky, Maria K., MD |
2003-07 | PHASE1 |
(data from https://clinicaltrials.gov, updated on 2026-09-04)
Check the
FK506 (Tacrolimus)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- FK506 (Tacrolimus) Mechanism of Action: Calcineurin Inhibition in T-Lymphocyte Research
- FK506 (Tacrolimus): Selectivity & Specificity
- FK506 (Tacrolimus) Working Concentration | Cell Culture | Treatment
- FK506 (Tacrolimus) Solubility in DMSO
- FK506 (Tacrolimus) Stock Solution
- FK506 (Tacrolimus) Storage
- FK506 (Tacrolimus) Stability
- FK506 (Tacrolimus) Combination Database
- FK506 (Tacrolimus) Molecular Weight
- FK506 (Tacrolimus) SMILES
- FK506 (Tacrolimus) CAS Number
- FK506 (Tacrolimus) Chemical Structure (2D and 3D)
- FK506 (Tacrolimus) IC50 for Cell-based and Cell-free Assays
- FK506 (Tacrolimus) MedChemExpress (HY-13756)? Try a better option.
- FK506 (Tacrolimus) Sigma (PHR1809)? Try a better option.
- FK506 (Tacrolimus) Tocris (3631)? Try a better option.
- FK506 (Tacrolimus) Abmole (M1934)? Try a better option.
- FK506 (Tacrolimus) Cayman (10007965)? Try a better option.
- FK506 (Tacrolimus) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.